| 23 March 2020 | Through early preventive actions Sciomics is fully operational to address your protein profiling and biomarker projects. Thanks to our core laboratory team which is doing a fantastic job, while most of our employees are collaborating with you from home.
Stay heatlthy in these challenging times !
> more information
| Jan 2019 | In the article, scientists at Tel Aviv University used our scioDiscover platform to analyse tumor-associated eosinophils in colorectal cancer. The full article is published in Cancer Immunology Research.
| June 2018 | Complement component 5a receptor 2 (C5AR2) deficient mice are protected from inflammation and fibrosis in response to ischemia reperfusion injury. Our scioPhospho platform supported scientists at the Medical School Hannover to elucidate the underlying mechanism. The data were recently published in Kidney International.
| January 2018 | A scioDiscover protein microarray study contributed to an article in Cell Reports. In this study Gerard Ruiz-Babot et al. analysed a donor specific reprogramming of cells.
Customer testimonial Leonardo Guasti, PhD (senior author):
This has undoubtedly opened new avenues in our research. We have found the Sciomics team to be extremely helpful and efficient during the whole process, from advising the best strategy to the final interpretation of results.
| January 2018 | Article on the StartUp Sciomics and our antibody microarray platform by our partner SCHOTT nexterion.
@MCDS_Therapy Welcome back and stay healthy !
RT @car_endo: #Antibodies are highly specific molecules, which recognizes a unique pattern, also called epitope, of a particular #protein.…
RT @car_endo: At Sciomics (@sciomics), the search for new protein #biomarkers is conducted using #antibody #microarray. Hundreds of differe…
RT @BioRNCluster: A new flavour to the traditional "Stammtisch". ☕️#BioRNEspresso: ‘Reacting to Covid-19 pandemic’: How emerging #biotechs…